Episcleritis

Episcleritis is an inflammation of the episclera, which is the thin layer of loose tissue just above the white part of the eye (the sclera) and under the clear covering (conjunctiva). When this layer becomes inflamed, the small blood vessels there get bigger, making the eye look red or pink. The inflammation is usually mild, does not threaten sight, and often goes away on its own. Most of the time, doctors do not find any clear reason—this is called idiopathic episcleritis—but sometimes it happens together with other body problems like autoimmune diseases or infections. The condition can come back again and again in some people, especially if there is an underlying disease. Episcleritis feels uncomfortable but usually causes only mild pain or irritation, not the deep aching pain seen in more serious eye inflammation like scleritis. NCBIEyeWikiMedscapeMerck Manuals

Episcleritis is swelling and inflammation of the episclera, a very thin layer of tissue that sits just above the white part of the eye (the sclera) and beneath the conjunctiva. The inflammation makes the eye look red or pink, often in a localized patch or diffusely across the white, and sometimes produces mild irritation or tearing. It usually does not cause deep pain, vision loss, or discharge, which helps distinguish it from more serious red-eye conditions. Most cases are short-lived and get better on their own, but some recur or are linked to systemic inflammatory diseases. NCBI EyeWiki Medscape

---

Types of Episcleritis

There are two main types of episcleritis, and understanding them helps doctors predict how long it will last, how bad it will feel, and whether to look for underlying causes.

1. Simple (Diffuse) Episcleritis:
This is the most common form. The redness is spread out over a part or most of the white of the eye. There is no firm bump. Episodes usually start suddenly and last from one to three weeks. Most people recover fully without long-term problems. Simple episcleritis is often short-lived and less likely to be linked to a serious underlying disease than nodular forms. EyeWikiMedscape

2. Nodular Episcleritis:
In this form, there is a small, raised, tender bump or nodule on the episclera. The redness is localized around that nodule. These episodes tend to last longer, can hurt a bit more, and are more likely to happen in people who also have a systemic inflammatory condition. Nodular episcleritis is more often recurrent and sometimes signals an underlying autoimmune disease. EyeWikiMedscape

Some authors also describe sectoral (a localized segment) involvement and recurrent episodic patterns, where the inflammation comes back periodically—sometimes linked to seasonal changes or underlying disease activity. Medscape

Because episcleritis affects the superficial tissues, applying certain drops (like phenylephrine) causes the redness to blanch (fade), which helps separate it from deeper inflammation like scleritis. MedscapeMedscape

---

Causes of Episcleritis

1. Idiopathic: Most cases have no clear trigger or disease found. NCBI

2. Rheumatoid arthritis: A common autoimmune joint disease that often affects the eyes. PMCResearchGate

3. Systemic lupus erythematosus (Lupus): Another autoimmune condition causing inflammation in many body parts, including the eye’s surface. Patient InfoUnbound Medicine

4. Inflammatory bowel disease (Crohn’s disease and ulcerative colitis): Gut inflammation that can have eye involvement. Patient InfoPMC

5. Sarcoidosis: A disease causing tiny clumps of inflammatory cells in organs, sometimes showing up in the eye. ScienceDirectUnbound Medicine

6. Behçet disease: A condition with recurring mouth/genital ulcers and eye inflammation including episcleritis. Medscape

7. HLA-B27 associated diseases (like ankylosing spondylitis, reactive arthritis, psoriatic arthritis): Genetic-related inflammatory diseases that can cause episcleritis. Medscape

8. Relapsing polychondritis: Inflammation of cartilage that can extend to structures around the eye. ResearchGate

9. VEXAS syndrome: A recently described inflammatory syndrome that has been linked to episcleritis. Medscape

10. Gout: Deposits of uric acid crystals and systemic inflammation can trigger eye surface inflammation. Medscape

11. Atopic conditions (allergies): General inflammation and irritation of ocular surface may contribute. Medscape

12. Acne rosacea: Skin inflammation that often affects the eyes and can be associated with episcleritis. Medscape

13. Herpes zoster virus infection (shingles affecting the eye): Viral reactivation can inflame superficial ocular tissues. Patient InfoPatient Info

14. Herpes simplex virus: Another viral cause of superficial ocular inflammation. Patient Info

15. Lyme disease: Tick-borne infection sometimes linked to inflammatory eye conditions like episcleritis. NCBIPatient Info

16. Syphilis: A sexually transmitted infection that can cause various eye inflammations. Unbound Medicine

17. Tuberculosis: Mycobacterial infection can be associated with eye surface inflammation in some cases. ScienceDirectUnbound Medicine

18. Brucellosis and other rare infections: Zoonotic or less common pathogens have been reported to cause episcleritis. Patient Info

19. Medication-induced paradoxical inflammation (e.g., TNF-alpha inhibitors like etanercept): Some immune drugs can trigger inflammatory eye findings. Medscape

20. Recent vaccination (e.g., COVID-19 vaccine) or environmental ocular surface irritation (dryness, foreign body, contact lens irritation): These can provoke or unmask mild episcleral inflammation. MedscapeMedscape

---

Symptoms of Episcleritis

1. Redness of the eye: Usually sudden, localized or diffuse, and often the first noticeable sign. EyeWikiMedscape

2. Visible bump or nodule (in nodular type): A small raised, red area on the white part of the eye. EyeWikiMedscape

3. Mild pain or tenderness: Often described as a dull ache or discomfort, usually not severe. DynaMedReview of Optometry

4. Foreign body sensation: Feeling like something is in the eye. ScienceDirectMerck Manuals

5. Tearing (watering): Reflex tearing due to mild irritation. Merck Manuals

6. Mild sensitivity to light (photophobia): Usually less than in deeper inflammations. MedscapeMedscape

7. Itching: May occur, and sometimes overlaps with allergic irritation. Medscape

8. Burning sensation: Described as irritation or warmth on the surface. Merck Manuals

9. Eye fatigue or heaviness: General sense of the eye feeling “off” or tired. Medscape

10. Mild blurring of vision (rare): Usually minimal and may occur if associated swelling is present. Medscape

11. Recurrent episodes: Episodes can come back, especially if underlying systemic disease exists. Medscape

12. Dryness sensation: Some patients feel the eye is dry even while tearing. Merck Manuals

13. Localized heat or warmth: Mild inflammation may create a sensation of warmth over the affected area. DynaMedReview of Optometry

14. Mild headache near the eye: Slight discomfort radiating from periocular inflammation. Review of Optometry

15. Normal or near-normal vision: Unlike more serious conditions, vision is usually unaffected; this absence of visual loss helps distinguish episcleritis. EyeWikiMerck Manuals

---

Diagnostic Tests for Episcleritis

A. Physical Exam

1. Patient history: Asking when redness started, whether it’s recurrent, any systemic symptoms (joint pain, rashes, gastrointestinal issues), medications, or recent infections. Medscape

2. External inspection: Looking for the pattern of redness (diffuse versus localized), presence of a nodule, and checking for discharge or eyelid changes. MedscapeEyeWiki

3. Slit-lamp examination: The ophthalmologist uses a microscope with a light to see the episclera closely; this confirms superficial vessel involvement and edema of episcleral tissue. MedscapeMedscape

4. Phenylephrine blanching test: Instillation of phenylephrine drops causes the superficial redness of episcleritis to fade (blanch), helping to distinguish it from deeper inflammation like scleritis which does not blanch. MedscapeDynaMed

B. Manual / Bedside Functional Tests 

1. Palpation for tenderness and intraocular pressure estimation: Gentle digital palpation can assess tenderness; measuring eyeball firmness helps rule out deeper inflammation. Review of Optometry
2. Nodule mobility assessment: Applying gentle pressure to a nodular area to see if the nodule moves slightly over the sclera distinguishes episcleral nodules from fixed deeper lesions. Wikipedia
3. Corneal esthesiometry (nerve sensitivity test): Checking corneal sensation can help rule out concurrent surface nerve problems or neurological masqueraders; abnormal findings would prompt broader evaluation. Medscape

C. Laboratory and Pathological Tests

1. Inflammation panel (ESR and CRP, plus CBC with differential): Measures general inflammation and infection, which guide whether systemic disease may be present. NCBIMedscape
2. Rheumatoid panel (Rheumatoid factor and anti-CCP): To detect rheumatoid arthritis, a common systemic association. PMCResearchGate
3. Antinuclear antibody (ANA): To screen for lupus and other connective tissue diseases. Patient InfoUnbound Medicine
4. ANCA (anti-neutrophil cytoplasmic antibody): Used when vasculitis like granulomatosis with polyangiitis is suspected. clinicaloptometry.scholasticahq.com
5. HLA-B27 testing: For spondyloarthropathies that associate with episcleritis. Medscape
6. Syphilis serology (RPR with confirmatory FTA-ABS): To detect syphilis-related ocular inflammation. Unbound Medicine
7. Lyme disease antibodies: If tick exposure or regional risk is present; Lyme infection can be a trigger. Patient Info
8. Tuberculosis screening (PPD or IGRA): When TB exposure or signs of systemic TB are present, since TB can cause ocular surface inflammation. ScienceDirectUnbound Medicine

D. Electrodiagnostic / Functional Neurologic Tests 

1. Visual evoked potentials (VEP): Not standard for routine episcleritis, but used in atypical cases where vision change or neurological involvement is suspected to rule out optic nerve or posterior pathway disease. Medscape
   17. Corneal nerve function testing (e.g., esthesiometry interpreted in functional context): Helps distinguish surface irritation from inflammation and assess any nerve dysfunction contributing to symptoms. Medscape

E. Imaging Tests 

1. Anterior segment optical coherence tomography (AS-OCT): High-resolution imaging to verify superficial vs deeper tissue involvement and to help rule out progression toward scleritis. Medscape
2. B-scan ultrasonography: Used when deeper inflammation such as scleritis is in doubt, to assess posterior extension or scleral thickening. clinicaloptometry.scholasticahq.comMedscape
3. Orbital MRI or CT scan: Reserved for unusual or severe cases to evaluate deeper ocular or orbital inflammation, rule out masquerading masses, and confirm absence of posterior scleritis or adjacent tissue disease. Medscape

Non-Pharmacological Treatments

1. Cold Compresses: Gently applied cold packs or chilled clean cloths over the closed eyelid reduce blood vessel dilation and mild swelling, calming the redness and discomfort. It works by constricting superficial vessels and slowing local inflammatory mediator activity. Use for 5–10 minutes several times daily. Medscape

2. Artificial Tears / Lubrication: Preservative-free lubricating drops keep the ocular surface moist, reduce friction from blinking, and dilute mild irritants. They soothe the eye and can shorten symptoms by improving surface comfort, even though they do not directly treat inflammation. MedscapeMedscape

3. Avoiding Eye Rubbing: Rubbing can mechanically irritate the already inflamed episclera, worsen redness, and sometimes trigger flares. Conscious avoidance prevents added trauma and secondary inflammation. PMC

4. Environmental Control (Humidifiers and Allergen Reduction): Dry air and airborne allergens (dust, smoke, pollen) irritate the ocular surface. Using a humidifier, keeping living spaces clean, and filtering out smoke or chemical irritants lowers baseline irritation and reduces recurrence risk. PMC

5. Sunglasses / UV Protection: Wearing sunglasses outdoors shields the eyes from ultraviolet light, wind, and glare, which can exacerbate superficial inflammation and provoke discomfort. UV has mild pro-inflammatory effects on ocular surface tissues. EyeWiki

6. Good Sleep and Stress Reduction: Chronic stress and poor sleep impair immune regulation and increase susceptibility to inflammatory flares. Techniques like mindfulness, gentle exercise, and sleep hygiene help stabilize systemic immune response, indirectly reducing episodes. PMC

7. Hydration and Healthy Fluid Intake: Adequate body hydration supports tear film health and epithelial maintenance. Dehydration concentrates inflammatory mediators and impairs healing. Drinking enough water daily keeps ocular tissues better perfused. PMC

8. Managing Underlying Systemic Disease: Early diagnosis and control of associated autoimmune diseases (like rheumatoid arthritis or lupus) reduces the frequency of episcleritis flares, because systemic inflammation often “spills over” to ocular tissues. Timely rheumatology care is key. Medscape

9. Eyelid Hygiene: Cleaning eyelid margins gently if blepharitis or meibomian gland dysfunction coexists reduces inflammatory load on the ocular surface. Warm compress followed by gentle scrub of lashes improves tear quality and reduces secondary irritation. BMRAtt

10. Screen Time Limitation / Frequent Breaks: Staring at screens reduces blinking leading to surface dryness and mild irritation; micro-breaks help maintain tear film and prevent additional superficial inflammation that may aggravate episcleritis. PMC

11. Anti-inflammatory Diet: Eating foods rich in natural anti-inflammatory compounds (e.g., berries, leafy greens, fatty fish) supports systemic immune balance and reduces overall inflammatory tone, making ocular flares less likely. MDPI

12. Smoking Cessation / Avoiding Secondhand Smoke: Tobacco smoke contains irritants and pro-inflammatory substances that worsen ocular surface irritation and delay resolution of inflammation. Quitting supports faster healing. PMC

13. Moderate Regular Exercise: Exercise improves circulation and systemic immune regulation and has been shown to lower chronic inflammatory markers, indirectly reducing susceptibility to mild inflammatory ocular conditions. PMC

14. Weight and Blood Sugar Control: Metabolic inflammation (e.g., from obesity or poorly controlled diabetes) primes the immune system toward heightened reactivity. Keeping weight and glucose in healthy ranges reduces background inflammation and helps prevent flares. Medscape

15. Avoiding Contact Lens Use During Flares: Contact lenses can mechanically irritate an inflamed eye and trap microbes or allergens. Temporarily stopping use allows the episclera to heal without added stress. Medscape

16. Protective Eyewear in Dusty/Chemical Settings: Shielding eyes from debris, chemical splashes, or irritant exposures prevents triggering inflammatory episodes. Goggles reduce direct environmental insult. PMC

17. Gentle Eye Cleansing (with Clean Water): Flushing the eye with clean, cool water can rinse mild surface irritants and allergens, reducing immediate discomfort without drugs. PMC

18. Avoiding Known Personal Triggers: For patients with recurrent episcleritis, tracking and avoiding individual triggers (e.g., certain cosmetics, seasonal allergens, stress periods) helps prevent future episodes. Medscape

19. Regular Eye Exams: Routine check-ins allow early detection of subtle underlying causes (e.g., autoimmune markers) and prevent mislabeling more serious conditions like scleritis. Early evaluation reduces progression risk. Medscape

20. Cold Artificial Tear Eye Masks: Combining lubrication with cool temperature, specialized eye masks help both moisturize and reduce local vessel dilation, doubling symptomatic relief. (Extension of cold compress + lubrication strategy). Medscape

---

Drug Treatments (Evidence-Based)

1. Topical Corticosteroids – Loteprednol Etabonate 0.5%: This mild steroid eye drop is used for moderate or persistent episcleritis. The typical course is 2–4 times daily for 1–2 weeks, tapering as redness improves. Purpose is to suppress local inflammation by blocking inflammatory cytokine production. Mechanism: glucocorticoid receptor-mediated inhibition of inflammatory gene transcription. Side effects are minimal with short courses but can include increased intraocular pressure and, rarely, cataract formation if prolonged. Medscape

2. Topical Corticosteroids – Prednisolone Acetate 1%: Stronger than loteprednol, used in nodular or stubborn cases. Dosage often starts 4 times daily, then taper over 1–2 weeks. It reduces immune cell recruitment and inflammatory mediator release. Risks include raised eye pressure, infection if used improperly, and cataract with prolonged use. Medscape

3. Topical Corticosteroids – Dexamethasone 0.1%: Another potent topical steroid for short courses in severe or unresolved inflammation. Used similarly with careful monitoring for steroid side effects, particularly glaucoma in susceptible individuals. Medscape

4. Topical Nonsteroidal Anti-inflammatory Drugs (NSAIDs) – Ketorolac Tromethamine 0.5%: Drops used to reduce mild inflammation and discomfort when steroids are not preferred or as adjunct in mild cases. Mechanism: cyclooxygenase inhibition reducing prostaglandin synthesis. Typical use is 4 times daily for limited duration. Side effects can include burning, stinging, and very rarely corneal complications if misused. Medscape

5. Oral NSAIDs – Ibuprofen (e.g., 400 mg every 6–8 hours as needed): Used when topical therapy is insufficient or for patients who prefer systemic control of mild inflammation. Purpose is to reduce inflammation and discomfort; mechanism is systemic cyclooxygenase inhibition. Side effects include stomach upset, kidney strain, and increased bleeding risk if overused. Medscape

6. Oral NSAIDs – Naproxen (e.g., 250–500 mg twice daily): Longer-acting alternative to ibuprofen, useful for sustained mild inflammation. Same mechanism as other NSAIDs. Gastrointestinal protection may be needed in sensitive patients. Medscape

7. Oral Corticosteroids – Prednisone (low dose, e.g., 10–20 mg daily with taper): Reserved for severe, bilateral, or recurrent cases especially if associated with systemic autoimmune disease. Purpose is wide suppression of immune overactivity. Mechanism: systemic glucocorticoid receptor-mediated transcriptional suppression of inflammatory genes. Side effects with systemic use are broad—weight gain, elevated blood sugar, mood changes, infection risk, and adrenal suppression if prolonged. Medscape

8. Systemic Immunomodulators – Methotrexate: When episcleritis is part of a systemic autoimmune disease (e.g., rheumatoid arthritis) that is poorly controlled, low-dose methotrexate may be used under specialist guidance to reduce underlying inflammation and prevent ocular flares. Mechanism: folate antagonist reducing proliferative immune cell activity. Side effects require monitoring: liver function, blood counts. Medscape

9. Systemic Immunomodulators – Hydroxychloroquine: Used in certain connective tissue diseases associated with ocular inflammation. It has anti-inflammatory and immune-modulating effects by interfering with antigen presentation and toll-like receptor signaling. Generally well tolerated but requires retinal screening for long-term use. Medscape

10. Adjunctive Topical Lubricant with Anti-inflammatory Additives: Some advanced lubricants include mild anti-inflammatory components (e.g., sodium hyaluronate) that help maintain surface health while providing symptomatic relief. They are used frequently throughout the day to reduce mechanical irritation and support healing. Medscape

---

Dietary Molecular Supplements

1. Omega-3 Fatty Acids (EPA/DHA): Typical dosage is 1000–3000 mg daily of combined EPA/DHA. These fatty acids reduce systemic inflammation by modulating eicosanoid synthesis, balancing prostaglandins, and promoting resolvins which help resolve ocular surface irritation. They are widely used for dry eye and may lower baseline inflammatory tone that could contribute to episcleritis flares. MDPI

2. Turmeric / Curcumin (standardized extract with enhanced bioavailability, 500–1000 mg twice daily): Curcumin has anti-inflammatory properties by inhibiting NF-κB and reducing cytokine production. It can help dampen low-grade systemic inflammation, indirectly decreasing risk of ocular inflammatory episodes. Supplementation should use formulations with piperine or phospholipid complexes to enhance absorption. MDPI

3. Quercetin (500 mg twice daily): A flavonoid with antioxidant and anti-inflammatory activity, quercetin stabilizes mast cells and reduces inflammatory mediator release, possibly helping reduce triggers in inflammation-prone individuals. MDPI

4. Vitamin D (1000–4000 IU daily depending on blood level): Vitamin D modulates immune response, promoting tolerance and reducing autoimmune-type inflammation. Adequate vitamin D status has been associated with lower incidence of various inflammatory conditions, and supplementation in deficient patients may help prevent flares. Medscape

5. Vitamin C (500–1000 mg daily): A strong antioxidant, vitamin C scavenges free radicals, supports collagen integrity in connective tissues, and contributes to immune regulation. It helps protect the superficial eye tissues from oxidative stress during inflammatory episodes. Medscape

6. Zinc (15–30 mg daily): Zinc is involved in immune function and wound healing. It supports epithelial health and may help the eye better withstand mild inflammation by supporting natural repair mechanisms. Excessive zinc should be avoided to prevent copper deficiency. Medscape

7. Lutein and Zeaxanthin (10–20 mg lutein + 2 mg zeaxanthin daily): While more commonly discussed for macular health, these carotenoids have antioxidant properties that help protect ocular tissues from light-related oxidative stress and support overall surface health. MDPI

8. Resveratrol (100–500 mg daily): A polyphenol that may decrease inflammatory cytokine production through modulation of sirtuins and NF-κB pathways. Its systemic anti-inflammatory effects could theoretically contribute to fewer episcleritis episodes. MDPI

9. Magnesium (200–400 mg daily): Magnesium has roles in immune regulation and may lower inflammation indirectly by improving vascular tone and reducing stress-related cortisol spikes. PMC

10. Green Tea Extract / EGCG (equivalent to 2–3 cups worth daily): Epigallocatechin gallate (EGCG) has anti-inflammatory and antioxidant effects, dampening cytokine cascades and potentially contributing to lower surface inflammation. MDPI

Note: These supplements are supportive. They do not replace acute therapy for active episcleritis but can help reduce the frequency or severity of recurrences when taken consistently and combined with lifestyle modifications. Always check for interactions with current medications. MDPI

---

Regenerative / Biologic (“Hard Immunity”) Approaches and Emerging Therapies

1. Autologous Serum Eye Drops (ASEDs): Made from a patient’s own blood serum diluted (commonly 20%), these drops supply natural growth factors (EGF, TGF-β), vitamins, and proteins that promote epithelial healing and reduce inflammation on the surface. They are used in refractory ocular surface disease and may help eyes with chronic irritation that could contribute to episcleritis-like symptoms. Typical regimen is multiple times daily for several weeks. PMCPubMedFrontiers

2. Platelet-Rich Plasma (PRP) Eye Drops: Concentrated platelets provide a rich mix of growth factors (like PDGF, VEGF) that stimulate tissue repair and modulate inflammation. PRP drops are used in severe dry eye and surface defects, improving comfort and reducing inflammatory markers; they may be considered when standard care fails. Treatment courses vary but often involve multiple daily instillations for several weeks. PMCPMCFrontiers

3. Mesenchymal Stem Cell (MSC) Eye Drops (e.g., Umbilical Cord-Derived): Early human trials show that MSC-derived eye drops have anti-inflammatory and regenerative effects on the ocular surface by releasing exosomes, altering immune cell behavior, and promoting epithelial recovery. These are experimental but promising for chronic surface inflammation. Dosing in pilot studies has been twice daily over several weeks with close follow-up. BioMed CentralWJGNet

4. Limbal Stem Cell / CALEC Therapy: CALEC (Cultivated Autologous Limbal Epithelial Cell) transplantation repairs severe corneal surface damage by restoring healthy epithelial stem cells. Though not directly a standard episcleritis treatment, improving ocular surface integrity reduces secondary irritation and may break cycles of superficial inflammation in complex or chronic ocular surface cases. Mass Eye and Ear

5. Amniotic Membrane Transplantation (Surgical Biologic): Placing cryopreserved amniotic membrane on the ocular surface provides anti-inflammatory growth factors and a scaffold for healing; it suppresses inflammation and encourages epithelial regeneration in severe or complicated surface disease. The procedure is typically done in a clinic or minor OR setting. MDPI

6. Allogeneic PRP / Blood Derivatives (for autoimmune-associated severe surface disease): When autologous sources are limited (e.g., poor venous access or systemic conditions), allogeneic PRP has been used with promising results in severe dry eye linked to systemic autoimmune disorders, showing clinical improvement in staining and comfort. Frontiers

Important Note: None of these regenerative therapies are first-line for simple episcleritis. They are primarily used to treat or heal complex ocular surface inflammation which, if present, may influence chronicity or recurrent superficial ocular inflammation. Many remain under investigation and may not yet be universally available or approved for episcleritis specifically. Harvard Stem Cell Institute

---

Procedures / Surgical Interventions

1. Episcleral or Scleral Biopsy: If redness is atypical, persistent, worsening, or if there is concern for deeper inflammation (e.g., to rule out scleritis, infection, or masquerade syndromes), a small tissue biopsy may be taken for histological diagnosis. This is diagnostic rather than therapeutic. Medscape

2. Amniotic Membrane Placement (Surgical): In cases where coexisting severe ocular surface disease is prolonging inflammation, surgical placement of an amniotic membrane can protect the surface and deliver anti-inflammatory signals. MDPI

3. Conjunctival Flap: When surface disease threatens corneal or scleral health (rarely in complicated or misdiagnosed overlapping conditions), a conjunctival flap can cover and protect tissue, reducing irritation and secondary inflammation. Medscape

4. Tarsorrhaphy (Temporary Eyelid Closure): For severe surface exposure or inflammation that cannot heal due to mechanical stress, partially sewing the eyelids together reduces exposure, allowing underlying tissues to calm. This is adjunctive and not for uncomplicated episcleritis. Medscape

5. Punctal Plugs / Occlusion: Minimally invasive procedure to conserve tears for patients with coexisting surface dryness, reducing mechanical irritation that might exacerbate superficial inflammation. This can help maintain a healthier surface environment during healing. Medscape

---

Prevention Strategies

1. Control Underlying Autoimmune or Systemic Inflammation: Keeping diseases like rheumatoid arthritis or lupus under good control reduces flare triggers. Medscape

2. Avoid Eye Rubbing: Prevent mechanical irritation. PMC

3. Protect Eyes from UV and Environmental Irritants: Use sunglasses and avoid smoke/chemicals. EyeWiki

4. Practice Good Eyelid Hygiene: Reduces secondary surface inflammation. BMRAtt

5. Stay Hydrated and Sleep Well: Supports overall immune balance. PMC

6. Manage Stress: Chronic stress can trigger flares; relaxation techniques help. PMC

7. Regular Eye Checkups: Early identification of warning signs and systemic associations. Medscape

8. Limit Contact Lens Use During Irritation: Avoid introducing new irritation. Medscape

9. Eat an Anti-inflammatory Diet: Reduces baseline inflammatory state. MDPI

10. Avoid Known Personal Triggers: Tailor prevention based on identified patterns. Medscape

---

When to See a Doctor

If any of the following happen, prompt medical evaluation is needed: redness lasting more than two weeks without improvement, deep or severe eye pain (suggests scleritis), vision changes or blurriness, significant light sensitivity (photophobia), discharge or pus, recurrent episodes that are increasing in frequency, systemic symptoms like joint pain, rash, fever (suggesting an underlying systemic inflammatory disease), or if the redness does not respond to over-the-counter soothing measures. Early evaluation helps rule out more serious conditions and starts appropriate therapy. Medscape

---

What to Eat and What to Avoid

Eat (help inflammation and ocular surface health):

1. Fatty fish (salmon, mackerel) for omega-3s.

2. Leafy greens (spinach, kale) for antioxidants and carotenoids.

3. Berries (blueberries, strawberries) rich in flavonoids.

4. Nuts (walnuts, almonds) for healthy fats and zinc.

5. Turmeric and ginger for natural anti-inflammation.

6. Citrus fruits for vitamin C.

7. Whole grains to reduce glycemic spikes and systemic inflammation.

8. Lean protein to support tissue repair.

9. Foods fortified with vitamin D or safe sun exposure for vitamin D status.

10. Water-rich fruits and adequate fluids to maintain hydration. MDPIMedscape

Avoid (reduce triggers and systemic inflammation):

1. Processed sugars and high-fructose foods that raise inflammatory markers.

2. Trans fats (fried snacks, hydrogenated oils) that promote inflammation.

3. Excessive alcohol, which can dehydrate and dysregulate immunity.

4. Highly salty foods that can affect vascular tone and tear film.

5. Artificial additives and preservatives if they correlate with flare patterns.

6. Smoking and secondhand smoke.

7. Excessively spicy or irritating foods in sensitive individuals (if they correlate).

8. Overconsumption of omega-6 heavy oils (balance with omega-3).

9. Foods that the individual is personally allergic to or sensitive to.

10. Excessive caffeine if it causes dehydration or blinking reduction in some individuals. PMCMedscape

---

Frequently Asked Questions (FAQs)

1. Is episcleritis serious?
   Most of the time, no. Episcleritis is usually mild and self-limited, but if it is recurrent, persistent, or accompanied by deep eye pain or vision change, evaluation is needed to rule out scleritis or systemic disease. Medscape

2. How long does episcleritis last?
   Simple cases often improve in a few days to a couple of weeks, especially with supportive care. Nodular forms may last longer or recur. EyeWiki

3. Can episcleritis cause vision loss?
   Not directly. Vision loss would be unusual and suggests a deeper condition like scleritis or concurrent ocular surface damage—those need prompt evaluation. Medscape

4. Is episcleritis contagious?
   No. It is usually inflammatory or autoimmune in origin, not infectious, so it does not spread person to person. PMC

5. What is the difference between episcleritis and scleritis?
   Episcleritis is superficial, causes mild discomfort, and blanches with vasoconstrictors. Scleritis is deeper, causes severe deep pain, may threaten vision, and does not blanch. Scleritis often signals more serious systemic disease. Medscape

6. Can I use over-the-counter eye drops?
   Yes, preservative-free artificial tears are safe and helpful. Avoid overusing vasoconstrictor “redness” drops, as they can rebound and mask worsening inflammation. Medscape

7. When are steroids needed?
   If the redness is persistent, bothersome, nodular, or not improving with simple measures, short courses of topical steroids (like loteprednol or prednisolone) prescribed by a doctor are common. They reduce inflammation quickly. Medscape

8. Can underlying disease cause episcleritis?
   Yes. Conditions like rheumatoid arthritis, lupus, and other autoimmune diseases are linked with episcleritis, so recurrent or bilateral cases often lead doctors to screen for systemic causes. Medscape

9. Should I stop wearing contact lenses?
   Yes, during an active flare. Contacts can irritate and delay healing. Resume only after the inflammation fully settles and with clinician approval. Medscape

10. Are there natural ways to prevent recurrence?
    Yes: controlling systemic inflammation, eating anti-inflammatory foods, avoiding known triggers, keeping eyes lubricated, and managing stress help prevent flares. MDPIMedscape

11. Is surgery needed for episcleritis?
    Rarely. Surgery is mostly diagnostic (biopsy) or used when surface disease is complicated (e.g., amniotic membrane placement). Simple episcleritis rarely, if ever, needs surgery. Medscape

12. Can supplements help?
    Supportive supplements (omega-3s, vitamin D, lutein, etc.) may reduce baseline inflammation and help tear film health, but they do not replace targeted therapy for active disease. MDPI

13. What if redness keeps coming back?
    Recurrent episcleritis should prompt evaluation for underlying autoimmune or systemic causes. A specialist may order blood tests or imaging depending on the pattern. Medscape

14. Are regenerative biologics useful?
    In complex or chronic ocular surface inflammation that overlaps or prolongs healing, biologics like autologous serum, PRP drops, or experimental MSC therapies have shown benefit in improving surface health, which can indirectly reduce episodes. PMCPMCBioMed Central

15. Can I self-diagnose episcleritis?
    Mild cases may look obvious (localized red patch with mild irritation), but because red eye can have serious causes, any atypical features (pain, vision change, discharge) should lead to professional evaluation to ensure safety. Medscape

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 03, 2025.